Ginkgo Bioworks Holdings (DNA) Prepaid Assets (2020 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Prepaid Assets came in at $17.4 million in Q2 2026, down 33.76% on a YoY basis from $26.2 million in Q2 2025, and up 6.96% quarter-over-quarter from $16.2 million in Q1 2026.
Analysis
Ginkgo Bioworks Holdings (DNA) Prepaid Assets (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Prepaid Assets for 7 consecutive years, with $17.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Prepaid Assets fell 33.76% year-over-year to $17.4 million; the trailing twelve-month figure through Jun 2026 stood at $17.4 million (down 33.76% YoY), and the FY2025 full-year result was $25.0 million, up 33.29% from the prior year.
- Prepaid Assets improved to $17.4 million in Q2 2026 per DNA's latest filing, from $16.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $51.8 million in Q4 2022 and bottomed at $16.2 million in Q1 2026.
- Historically, Prepaid Assets has averaged $30.7 million across 5 years, with a median of $31.2 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 4066.48% in 2022, then plunged 52.92% in 2024.
- Over 5 years, Prepaid Assets stood at $51.8 million in 2022, then dropped by 23.24% to $39.8 million in 2023, then slumped by 52.92% to $18.7 million in 2024, then jumped by 33.29% to $25.0 million in 2025, then plunged by 30.46% to $17.4 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $17.4 million, $16.2 million, and $25.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.36 Mn |
| Mar 31, 2026 | 16.23 Mn |
| Dec 31, 2025 | 24.96 Mn |
| Sep 30, 2025 | 21.86 Mn |
| Jun 30, 2025 | 26.21 Mn |
| Mar 31, 2025 | 20.44 Mn |
| Dec 31, 2024 | 18.73 Mn |
| Sep 30, 2024 | 22.32 Mn |
| Jun 30, 2024 | 34.10 Mn |
| Mar 31, 2024 | 38.02 Mn |
| Dec 31, 2023 | 39.78 Mn |
| Sep 30, 2023 | 29.39 Mn |
| Jun 30, 2023 | 48.36 Mn |
| Mar 31, 2023 | 33.87 Mn |
| Dec 31, 2022 | 51.82 Mn |
| Sep 30, 2022 | 37.78 Mn |
| Jun 30, 2022 | 38.72 Mn |
| Mar 31, 2022 | 33.09 Mn |
| Dec 31, 2021 | 33.54 Mn |
| Sep 30, 2021 | 17.31 Mn |